BONE-MARROW TRANSPLANTATION (BMT) FOR EPIPODOPHYLLOTOXIN-INDUCED SECONDARY ACUTE MYELOGENOUS LEUKEMIA (AML)

被引：0
|
作者：
SANDLER, ES
FRIEDMAN, DJ
MUSTAFA, MM
WINICK, NJ
BOWMAN, WP
BUCHANAN, GR
机构：
[1] UNIV TEXAS,SW MED CTR,DALLAS,TX 75230
[2] CHILDRENS MED CTR,DALLAS,TX 75235
[3] COOK FT WORTH CHILDRENS MED CTR,FT WORTH,TX
来源：
BLOOD | 1993年 / 82卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A167 / A167
页数：1
相关论文
共 50 条
  • [31] BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
    APPELBAUM, FR
    CLIFT, R
    RADICH, J
    ANASETTI, C
    BUCKNER, CD
    SEMINARS IN ONCOLOGY, 1995, 22 (04) : 405 - 411
  • [32] BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
    GOLDMAN, JM
    BORTIN, MM
    CHAMPLIN, RE
    HERZIG, RH
    MCGLAVE, PB
    MESSNER, HA
    RIMM, AA
    SPECK, B
    WEINER, RS
    LANCET, 1985, 2 (8467): : 1295 - 1295
  • [33] Unrelated donor marrow transplantation for acute myelogenous leukemia (AML), myelodysplasia, and secondary AML.
    Drobyski, WR
    Horowitz, M
    Pietryga, D
    Margolis, D
    Juckett, M
    Burns, W
    Camitta, B
    Rowlings, P
    KeeverTaylor, C
    Casper, J
    BLOOD, 1996, 88 (10) : 1063 - 1063
  • [34] BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) IN ACUTE CRISIS
    NAITO, K
    YAMADA, K
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (05) : 593 - 593
  • [35] CHEMOTHERAPY VERSUS BONE-MARROW TRANSPLANTATION IN ADULTS WITH ACUTE MYELOGENOUS LEUKEMIA
    LABAR, B
    MRSIC, M
    BOGDANIC, V
    NEMET, D
    RADMAN, I
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 575 - 575
  • [36] BONE-MARROW TRANSPLANTATION FOLLOWING BUSULFAN AND CYCLOPHOSPHAMIDE FOR ACUTE MYELOGENOUS LEUKEMIA
    CRILLEY, P
    TOPOLSKY, D
    BULOVA, S
    BIGLER, R
    BRODSKY, I
    BONE MARROW TRANSPLANTATION, 1990, 5 (03) : 187 - 191
  • [37] MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA (AML) IN REMISSION
    THOMAS, ED
    BUCKNER, CD
    FEFER, A
    JOHNSON, FL
    NEIMAN, P
    SANDERS, J
    STORB, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 30 - 30
  • [38] ALLOGENIC BONE-MARROW TRANSPLANTATION (BMT) IS THE MOST EFFECTIVE TREATMENT FOR ACUTE MYELOBLASTIC-LEUKEMIA (AML) IN CHILDHOOD
    SCHAISON, G
    MICHEL, G
    LANDMANPARKER, J
    BARUCHEL, A
    NELKEN, B
    BORDIGONI, P
    LEBLANC, T
    PEREL, Y
    BERGERON, C
    VANNIER, JP
    LAMAGNERE, JP
    THURET, I
    LEVERGER, G
    BLOOD, 1993, 82 (10) : A169 - A169
  • [39] Bone marrow transplantation (BMT) for acute myelogenous leukemia (AML): Impact of chemotherapy on long-term mortality and morbidity.
    Robin, M
    Guardiola, P
    Esperou, H
    Ribaud, P
    Devergie, A
    Dombret, H
    Gluckman, E
    Socie, G
    BLOOD, 2000, 96 (11) : 406A - 406A
  • [40] PROBLEMS AND STRATEGIES FOR BONE-MARROW TRANSPLANTATION IN ACUTE-LEUKEMIA AND CHRONIC MYELOGENOUS LEUKEMIA
    SANTOS, GW
    CANCER DETECTION AND PREVENTION, 1988, 12 (1-6): : 589 - 596
12345